![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
as a Selective Ligand for Prokineticin Receptor 1
Johnson & Johnson Pharmaceutical Research and Development, LLC, San Diego, California
Prokineticins 1 and 2 (PK1 and PK2) have been recently identified from humans and other mammals and play multiple functional roles. PK proteins are ligands for two G protein-coupled receptors, PK receptor 1 (PKR1) and PK receptor 2 (PKR2). Here, we report the molecular cloning and pharmacological characterization of an alternatively spliced product of the PK2 gene encoding 21 additional amino acids compared with PK2, designated PK2L (for PK2 long form). PK2L mRNA is broadly expressed, as is PK2. However, PK2L mRNA expression is lower in brain, undetectable in kidney, and much higher in lung and spleen than that of PK2. We expressed PK2L in mammalian cells and characterized the resulting peptide in comparison with PK1 and PK2. Biochemical characterization indicates that secreted PK2L protein is processed into a smaller peptide by proteolytic cleavage. We designate this smaller form of peptide as PK2
. Coexpression of furin with PK2L significantly increased the PK2 processing efficiency. Functional studies showed that PK1, PK2, and PK2 stimulate intracellular Ca2+ responses in PKR1-expressing cells with similar potencies. However, the PK2 stimulus of Ca2+ responses in PKR2-expressing cells is at least 10-fold less potent than that of PK1 or PK2. Differences in receptor selectivity combined with differential tissue expression patterns suggest PK2 and PK2 might have different functions in vivo. PKRs have been reported to couple to Gq and Gi proteins. In this report, we show that PKs not only stimulate Ca2+ mobilization but also induce cAMP accumulation in PKR-expressing cells.
Address correspondence to: Dr. Changlu Liu, 3210 Merryfield Row, San Diego, CA 92121. E-mail: cliu9{at}prdus.jnj.com
This article has been cited by other articles:
|
|
 |
|
  M. Keramidas, C. Faudot, A. Cibiel, J.-J. Feige, and M. Thomas Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells J. Endocrinol., March 1, 2008; 196(3): 473 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pitteloud, C. Zhang, D. Pignatelli, J.-D. Li, T. Raivio, L. W. Cole, L. Plummer, E. E. Jacobson-Dickman, P. L. Mellon, Q.-Y. Zhou, et al. From the Cover: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism PNAS, October 30, 2007; 104(44): 17447 - 17452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis FASEB J, September 1, 2007; 21(11): 2980 - 2993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-Y. Zhou The Prokineticins: A NOVEL PAIR OF REGULATORY PEPTIDES Mol. Interv., December 1, 2006; 6(6): 330 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li and K. A. Borkovich GPR-4 Is a Predicted G-Protein-Coupled Receptor Required for Carbon Source-Dependent Asexual Growth and Development in Neurospora crassa. Eukaryot. Cell, August 1, 2006; 5(8): 1287 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Matsumoto, C. Yamazaki, K.-h. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. PNAS, March 14, 2006; 103(11): 4140 - 4145. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
